Pharma Co. Wants €140M AOP Orphan Award Suit Tossed
Taiwanese pharmaceutical company PharmaEssentia renewed its bid to toss litigation over a disputed €142 million ($165 million) arbitral award secured by Austrian pharmaceutical company AOP Orphan, saying a Massachusetts federal court lacks...To view the full article, register now.
Already a subscriber? Click here to view full article